NFKB1 and prostate cancer: The IκB complex phosphorylates NFκB to activate the cellular response to inflammation (Bouwmeester et al., 2004; Hacker & Karin, 2006; Wen et al., 2000), suggesting that MEN1 may represent a novel upstream regulator of the pathway in prostate cancer.